|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-7-21
|
|
pubmed:abstractText |
Limited data are available on the cardiac effects of high-dose cyclophosphamide (CY) in patients with non-Hodgkin's lymphoma (NHL). We prospectively assessed the cardiac effects of high-dose CY in 30 adult NHL patients receiving CY 6 g/m(2) as part of BEAC high-dose therapy (HDT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Atrial Natriuretic Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Carmustine,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/N-terminal proatrial natriuretic...,
http://linkedlifedata.com/resource/pubmed/chemical/Natriuretic Peptide, Brain,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Precursors,
http://linkedlifedata.com/resource/pubmed/chemical/pro-brain natriuretic peptide (1-76)
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0902-4441
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
77
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
120-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16856907-Adult,
pubmed-meshheading:16856907-Aged,
pubmed-meshheading:16856907-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16856907-Atrial Natriuretic Factor,
pubmed-meshheading:16856907-Biological Markers,
pubmed-meshheading:16856907-Carmustine,
pubmed-meshheading:16856907-Cyclophosphamide,
pubmed-meshheading:16856907-Cytarabine,
pubmed-meshheading:16856907-Etoposide,
pubmed-meshheading:16856907-Female,
pubmed-meshheading:16856907-Gated Blood-Pool Imaging,
pubmed-meshheading:16856907-Heart,
pubmed-meshheading:16856907-Humans,
pubmed-meshheading:16856907-Lymphoma, Non-Hodgkin,
pubmed-meshheading:16856907-Male,
pubmed-meshheading:16856907-Middle Aged,
pubmed-meshheading:16856907-Natriuretic Peptide, Brain,
pubmed-meshheading:16856907-Peptide Fragments,
pubmed-meshheading:16856907-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:16856907-Postoperative Complications,
pubmed-meshheading:16856907-Postoperative Period,
pubmed-meshheading:16856907-Prospective Studies,
pubmed-meshheading:16856907-Protein Precursors,
pubmed-meshheading:16856907-Sensitivity and Specificity,
pubmed-meshheading:16856907-Stroke Volume,
pubmed-meshheading:16856907-Systole,
pubmed-meshheading:16856907-Transplantation, Autologous,
pubmed-meshheading:16856907-Ventricular Dysfunction, Left
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
|
|
pubmed:affiliation |
Department of Medicine, Kuopio University Hospital, Kuopio, Finland. taru.kuittinen@kuh.fi
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
